Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the first patients have been successfully treated for Inferior Vena Cava ...

Please provide your email address to receive an email when new articles are posted on . Royal Philips announced the FDA has granted breakthrough device designation for its laser-assisted inferior vena ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window FDA approved the ...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology today announced the FDA has granted De Novo Clearance for Philips IVC Filter Removal Laser ...

First use of Philips' breakthrough CavaClear solution to help patients with embedded IVC filters, including an athlete suffering from a 16-year old penetrating filter Only FDA-cleared solution for ...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the FDA has granted Breakthrough Device Designation (BDD) for a laser-assisted ...

First patients ‘filter free’ after laser-assisted Inferior Vena Cava (IVC) filter removal with Philips CavaClear GlobeNewswire April 21, 2022 First use of Philips' breakthrough CavaClear solution to ...

FDA Breakthrough Device Designation is granted to novel medical devices that have the potential to provide more effective treatment It is estimated that in the United States more than one million ...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the first patients have been successfully treated for Inferior Vena Cava ...